文献速递肿瘤 PET/CT

儿童霍奇金淋巴瘤中体积分析参数与淋巴瘤播散范围的预测及预后作用:一项前瞻性、多中心、队列研究

Predictive and prognostic role of volumetric analyses and lymphoma dissemination in pediatric HL: a prospective, multicenter, cohort study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-09-16

该前瞻性多中心队列研究纳入35个AIEOP中心的300例儿童霍奇金淋巴瘤患者,于基线、早期和晚期反应评估时行PET,分析SUVmax、SUVmean、Dmax、TMTV、TLG及其变化与反应和無事件生存的关系。基线体积参数和Dmax具预后价值,早期评估时半定量参数和Dmax具预后价值;联合因素可将患者分层为不同风险组。

要点

  • 基线PET所有参数与早期反应评估PET显著相关。
  • 基线时体积参数和Dmax具预后价值,早期评估时半定量参数和Dmax具预后价值。
  • 联合基线无风险因素与三个风险因素患者HR 17.701(p<0.0001)。

核心结论

  • 作者认为这是该类型首个大型、前瞻性、多中心儿童研究,证明PET体积参数在儿童霍奇金淋巴瘤中的作用,并首次在儿童中显示Dmax具有预测和预后作用。
  • 联合这些因素可基于结局将患者分层为风险组。

研究设计与样本

  • 前瞻性、多中心队列研究,在35个AIEOP中心开展,2018年3月至2020年12月纳入接受同一治疗方案试验的儿童霍奇金淋巴瘤患者,共300例。

主要发现

  • 300例患者中男性144例(48%),I-II期167例、III-IV期133例,大肿块(>200 ml)114例,B症状167例。
  • 基线PET所有参数与早期反应评估PET显著相关。
  • 基线PET时体积参数和Dmax具预后价值,早期反应评估PET时半定量参数和Dmax具预后价值。
  • 多因素分析显示基线PET时分期(p=0.0026)、大肿块体积(p<0.0001)和Dmax(p=0.0388)为独立预后因素;早期反应评估时Dmax(p=0.0025)和ΔSUVmax(p=0.0297)为独立预后因素。
  • 基线PET无风险因素患者与三个风险因素患者相比HR 17.701(p<0.0001);早期反应评估PET双因素风险患者结局最差,平均EFS 56.4个月(HR 23.489;p<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of the present trial is to investigate the predictive and prognostic role of PET volumetric parameters and maximal dissemination (Dmax) in pediatric Hodgkin lymphoma (HL). MATERIALS AND METHODS: This is a prospective, multicenter study conducted in 35 AIEOP centers. Between March 2018 and December 2020, pediatric HL patients undergoing the same therapeutic trial have been enrolled. Patients underwent PET at baseline (PET0), for early (ERA), and late response assessment (LRA). The parameters analyzed were SUVmax, SUVmean, Dmax, TMTV (total metabolic tumor volume), TLG (total lesion glycolysis), and their (Δ) variations at different timing. Clinical and imaging parameters have been correlated to response, classified into adequate (AR) and inadequate (IR), based on protocol definition, and the event-free survival (EFS). RESULTS: Overall, 300 patients were enrolled: 144 were male (48%), 167 stage I-II and 133 stage III-IV, 114 presented with bulky masses (> 200 ml), whereas 167 patients showed B-symptoms. All PET0 parameters resulted significantly correlated to ERA PET. With respect to the outcome, volumetric parameters and Dmax resulted prognostic at PET0, while semi-quantitative parameters and Dmax resulted prognostic at ERA PET. At multivariate analyses, an independent prognostic role was proven for stage (p = 0.0026), bulky volume (p < 0.0001), and Dmax (p = 0.0388) at PET0. Whereas, Dmax (p = 0.0025) and ΔSUVmax (p = 0.0297) resulted independent prognostic factors at ERA. By combining factors, we found a significant difference for patients with no risk factors at PET0 compared to patients with three risk factors (HR 17.701; p < 0.0001). At ERA PET, the poorest outcome was reached in case of bi-factorial risks, with a mean EFS of 56.4 months (HR 23.489; p < 0.0001). CONCLUSIONS: To our knowledge, this is the first large, prospective, multicenter study of its type in pediatric patients. Our findings demonstrate the role of PET volumetric parameters in pediatric HL. Moreover, as first evidence in children, Dmax showed a proper predictive and prognostic role in HL. By combining these factors, we could stratify patients into risk-groups based on the outcomes.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Lopci E, Elia C, De Re V, et al. Predictive and prognostic role of volumetric analyses and lymphoma dissemination in pediatric HL: a prospective, multicenter, cohort study. Eur J Nucl Med Mol Imaging. 2025. PMID: 40956409. doi:10.1007/s00259-025-07537-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。